多光谱成像技术在生物医学中的应用进展

多光谱成像(multispectral imaging,MSI)技术在生物医学可视化方面是一种新技术,它结合了两个已建立的光学模块:成像学和光谱学。它的原理是基于液晶可调谐滤光片,从可见光到近红外波长(400-970nm)区域获取多光谱图像。自从MSI系统加上显微镜商品化以来,MSI已经成为一种快速发展的领域,可应用于细胞生物学、临床前药物开发和临床病理学等。国外已有大量关于MSI在生物医学中应用的研究报道,但国内报道少见。本文主要对多光谱成像的基本原理,近三年内该技术在生物医学领域的应用进展作一简要综述。     

MALDI MSI技术在缺血性卒中研究中的应用

基质辅助激光解吸/电离质谱成像(MALDI MSI)技术是新兴的分子成像技术,具有免标记、高空间分辨、高检测特异性等优势,在捕捉、分辨和鉴定各种疾病相关代谢物的组织分布与变化方面具有明显的优势,为揭示多种目标分子在生理/病理条件下的组织空间分布特征及其时空动态变化提供了便利和直观的研究手段。综述了近年来MALDI MSI技术在缺血性卒中研究中的应用,重点阐述了运用MALDI MSI技术研究缺血性卒中发生发展过程中,多种结构与功能各异的内源性小分子在脑中的时空动态变化规律,以期为揭示缺血性卒中发病的分子机制提供科学依据。     

高光谱技术——生态学领域研究的新方法

高光谱技术是一种新的地物探测技术,该技术以其敏锐的地物光谱特征探测能力为精准识别地物属性提供了强有力的手段,在生态系统过程与属性研究中具有广阔的应用前景。该文以可见光-近红外光谱分析技术为例概述了高光谱技术的原理、特点与优势,以及高光谱技术分析的流程;总结并归纳了其在土壤、植物生理、农产品品质检测、凋落物分解方面的研究应用,指出高光谱技术与遥感成像技术结合在生态监测研究中的优势;归纳了高光谱技术应用中面临的问题,并希望高光谱技术在生态学领域研究中得到更广泛的应用。     

光谱多样性在植物多样性监测与评估中的应用

光谱多样性是一种基于植物反射电磁辐射光谱的生物多样性维度, 反映了不同波段光谱反射率在植物种内与种间个体之间的变异程度。由于植物反射光谱特征的差异可以综合地反映植物间生化组分和形态特征的差异, 光谱多样性成为植物多样性监测和评估的重要技术手段。该文介绍了光谱多样性的概念及其生态学意义, 比对了多源、多平台光谱数据各自的技术优势和局限性, 并概述了基于光谱多样性的植物多样性监测和评估方法及其应用, 探讨了光谱多样性整合不同维度生物多样性的能力, 展望了光谱多样性在生物多样性研究中的发展前景。光谱多样性能在多空间尺度服务于植物多样性的监测与评估, 特别是依托基于无人机技术的近地面遥感, 可以实现精细尺度植物多样性的监测与评估, 在生物多样性的保护和管理中具有广阔的应用前景。     

高光谱成像技术在生物医学中的应用

高光谱成像技术是传统成像与光谱技术相结合的一门新技术,其可同时获得被测物体的空间特征与光谱信息,以实现对物质特性的研究。本文介绍了高光谱成像技术的基本原理、系统的基本构成及特点,总结和阐述了近年来高光谱成像技术在生物医学领域的发展,以及其在疾病诊断中的应用。     

单细胞拉曼光谱在微生物研究中的应用

拉曼显微光谱是一种能够提供0.5–1.0μm空间分辨率的单个微生物细胞内化学结构信息的研究技术。近几年来,拉曼显微光谱被越来越多地应用于微生物单细胞的研究中,它可以快速无损地检测微生物细胞内的特征化学组分。典型的单个微生物细胞的拉曼光谱包含核酸、蛋白质、碳水化合物、脂质和色素(例如类胡萝卜素)等信息,这些信息能够表征微生物细胞的基因型、表型和生理状态。所以单细胞拉曼显微光谱是一种可用于区分微生物样品的"全生物指纹"技术,它可用于研究单个微生物细胞生命阶段的转变、鉴定微生物单细胞中的色素及其他化合物的含量变化等。本文综述了目前拉曼显微光谱在微生物单细胞研究上的应用,主要包括与稳定同位素标记(stable isotope probing,SIP)、拉曼成像、光谱分类和细胞分选技术结合来探究微生物单细胞对物质吸收后特征峰的变化、推导物质循环过程、进行微生物分类鉴定和探索基因型与表型的关系。拉曼显微光谱作为微生物单细胞研究的手段之一,在代谢过程的研究、活细胞分选和细胞对物质的利用上具有广泛的应用前景。     

桉树叶片光合色素含量高光谱估算模型

色素在植物的生理生态过程中非常重要,利用高光谱数据,揭示光谱反射率上特征波段与光合色素含量间的关系将有助于理解光合色素光谱反射特征的规律,同时为利用高光谱遥感技术快速无损监测植物叶片光合色素提供了技术支持.利用野外采集的桉树叶片样本,在实验室内测定了叶片的高光谱反射率及对应的叶绿素、类胡萝卜素含量.利用光谱分析技术和统计学方法对光谱数据进行处理分析,提取了光谱特征参量,并建立叶绿素、类胡萝卜素含量与光谱特征参量间的估算模型.通过精度检验,研究结果表明以(SDr-SDb)/(SDr+SDb)为变量建立的指数模型估算效果最佳.     

皮肤组织显微共聚焦拉曼光谱成像研究

显微共聚焦拉曼光谱成像技术(Confocal Raman Microspectroscopy Imaging,CRMI)能够对样品微区进行精确无损的拉曼光谱分析和光谱图像扫描,提供生物样品的无损高分辨光学信息。本项研究工作,利用CRMI技术实验获取了正常人体离体皮肤组织的拉曼光谱特征,并结合典型特征峰的扫描图像,探讨了脂类、蛋白质等成分在皮肤真皮层的分布特点。实验发现皮肤组织真皮层内胶原蛋白的拉曼特征峰1 248 cm-1强度及其空间分布尤为突出,这一实验结果与组织学中胶原纤维占真皮结缔组织95%的事实相符。实验结果显示,CRMI技术能够全面诠释生物组织内部生化组成与分布信息,在实验描述皮肤组织病理变化的分子生物学机制方面具有广阔的应用前景。     

植物反射光谱对水分生理变化响应的研究进展

实时、无损伤地探测植物的水分及生理变化是高光谱遥感的深层次应用。由水分胁迫引发的植物一系列反射光谱响应体现了碳-氮-水耦合作用的结果。以往的研究大多集中于单一因素的响应, 而忽略了多因素交互作用。该文综述和分析了植物水分状况变化引起的直接和间接光谱响应机制, 包括植物水分含量、色素、养分状况、光合作用和叶绿素荧光指标的光谱响应及其内在的关联, 探讨了反射光谱在探测植物水分生理活动应用中的主要方法与最新技术, 并指出碳-氮-水多指标、多时空尺度的综合分析对于估测植被生产力及其对气候变化的响应具有重要意义。     

两株植物内生巨大芽孢杆菌的生物学特性比较

分别从爬山虎和金银花的茎中分离和鉴定获得了两株植物内生巨大芽孢杆菌(Bacillus megaterium),并对其形态特征、生理生化特征、培养及生理特征进行研究和比较。结果显示,在菌体的大小、耐盐能力、利用柠檬酸盐和在10°C下生长情况、D-木糖的代谢和产卵黄磷脂酶情况等方面,不同植物的内生巨大芽孢杆菌间以及植物内生菌与外源菌间都存在较大差异。结果表明,表型分类法在植物内生菌的鉴定中存在一定局限。     

In situ metabolomic mass spectrometry imaging: recent advances and difficulties

MS imaging (MSI) is a remarkable new technology that enables us to determine the distribution of biological molecules present in tissue sections by direct ionization and detection. This technique is now widely used for in situ imaging of endogenous or exogenous molecules such as proteins, lipids, drugs and their metabolites, and it is a potential tool for pathological analysis and the investigation of disease mechanisms. MSI is also thought to be a technique that could be used for biomarker discovery with spatial information. The application of MSI to the study of endogenous metabolites has received considerable attention because metabolites are the result of the interactions of a system's genome with its environment and a total set of these metabolites more closely represents the phenotype of an organism under a given set of conditions. Recent studies have suggested the importance of in situ metabolite imaging in biological discovery and biomedical applications, but several issues regarding the technical application limits of MSI still remained to be resolved. In this review, we describe the capabilities of the latest MSI techniques for the imaging of endogenous metabolites in biological samples, and also discuss the technical problems and new challenges that need to be addressed for effective and widespread application of MSI in both preclinical and clinical settings.     

Imaging lipids in biological samples with surface-assisted laser desorption/ionization mass spectrometry: A concise review of the last decade

Knowing the spatial location of the lipid species present in biological samples is of paramount importance for the elucidation of pathological and physiological processes. In this context, mass spectrometry imaging (MSI) has emerged as a powerful technology allowing the visualization of the spatial distributions of biomolecules, including lipids, in complex biological samples. Among the different ionization methods available, the emerging surface-assisted laser desorption/ionization (SALDI) MSI offers unique capabilities for the study of lipids. This review describes the specific advantages of SALDI-MSI for lipid analysis, including the ability to perform analyses in both ionization modes with the same nanosubstrate, the detection of lipids characterized by low ionization efficiency in MALDI-MS, and the possibilities of surface modification to improve the detection of lipids. The complementarity of SALDI and MALDI-MSI is also discussed. Finally, this review presents data processing strategies applied in SALDI-MSI of lipids, as well as examples of applications of SALDI-MSI in biomedical lipidomics.     

空间分辨代谢组学进展和挑战

空间分辨代谢组学即整合质谱成像和代谢组学技术,对动/植物组织和细胞中内/外源性代谢物的种类、含量和差异性空间分布进行精准测定。质谱成像技术因其具有无标记、非特异、高灵敏度、高化学覆盖、元素/分子同时检测等优势,被广泛应用于动/植物组织中各类代谢物、多肽和蛋白的时空分布研究。首先介绍了代谢组学和质谱成像技术的研究现状,然后重点综述了空间分辨代谢组学在动物组织、植物组织和单细胞水平上的前沿应用。最后展望了空间分辨代谢组学技术的现有瓶颈和未来发展方向。空间分辨代谢组学是继代谢组学之后又一门新兴的分子成像组学技术,能够无标记、可视化检测动物组织中外源性药物的吸收、分布、代谢和排泄,以及植物组织中多种代谢产物的生物合成、转运途径和积累规律。该技术将推动靶向药物发现、病理机制解析和动植物生长发育密切关联的空间代谢网络调控等前沿应用研究。     

MALDI-imaging mass spectrometry - An emerging technique in plant biology

Recent advances in instrumentation and sample preparation have facilitated the mass spectrometric (MS) imaging of a large variety of biological molecules from small metabolites to large proteins. The technique can be applied at both the tissue and the single-cell level, and provides information regarding the spatial distribution of specific molecules. Nevertheless, the use of MS imaging in plant science remains far from routine, and there is still a need to adapt protocols to suit specific tissues. We present an overview of MALDI-imaging MS (MSI) technology and its use for the analysis of plant tissue. Recent methodological developments have been summarized, and the major challenges involved in using MALDI-MSI, including sample preparation, the analysis of metabolites and peptides, and strategies for data evaluation are all discussed. Some attention is given to the identification of differentially distributed compounds. To date, the use of MALDI-MSI in plant research has been limited. Examples include leaf surface metabolite maps, the characterization of soluble metabolite translocation in planta, and the profiling of protein/metabolite patterns in cereal grain cross-sections. Improvements to both sample preparation strategies and analytical platforms (aimed at both spectrum acquisition and post-acquisition analysis) will enhance the relevance of MALDI-MSI technology in plant research.     

Multispectral imaging in biology and medicine: slices of life.

Multispectral imaging (MSI) is currently in a period of transition from its role as an exotic technique to its being offered in one form or another by all the major microscopy manufacturers. This is because it provides solutions to some of the major challenges in fluorescence-based imaging, namely ameliorating the consequences of the presence of autofluorescence and the need to easily accommodate relatively high levels of signal multiplexing. MSI, which spectrally characterizes and computationally eliminates autofluorescence, enhances the signal-to-background dramatically, revealing otherwise obscured targets. While this article concentrates on examples derived from liquid-crystal tunable filter-based technology, the intent is to showcase the advantages of multispectral imaging in general. Some technologies used to generate multispectral images are compatible with only particular optical configurations, such as point-scanning laser confocal microscopy. Band-sequential approaches, such as those afforded by liquid-crystal tunable filters (LCTFs), can be conveniently coupled with a variety of imaging modalities, which, in addition to fluorescence microscopy, include brightfield (nonfluorescent) microscopy as well as small-animal, noninvasive in-vivo imaging. Brightfield microscopy is the chosen format for histopathology, which relies on immunohistochemistry to provide molecularly resolved clinical information. However, in contrast to fluorescent labels, multiple chromogens, if they spatially overlap, are much harder to separate and quantitate, unless MSI approaches are used. In-vivo imaging is a rapidly growing field with applications in basic biology, drug discovery, and clinical medicine. The sensitivity of fluorescence-based in-vivo imaging, as with fluorescence microscopy, can be limited by the presence of significant autofluorescence, a limitation which can be overcome through the utilization of MSI.     

FRET-FLIM applications in plant systems

A hallmark of cellular processes is the spatio-temporally regulated interplay of biochemical components. Assessing spatial information of molecular interactions within living cells is difficult using traditional biochemical methods. Developments in green fluorescent protein technology in combination with advances in fluorescence microscopy have revolutionised this field of research by providing the genetic tools to investigate the spatio-temporal dynamics of biomolecules in live cells. In particular, fluorescence lifetime imaging microscopy (FLIM) has become an inevitable technique for spatially resolving cellular processes and physical interactions of cellular components in real time based on the detection of Förster resonance energy transfer (FRET). In this review, we provide a theoretical background of FLIM as well as FRET-FLIM analysis. Furthermore, we show two cases in which advanced microscopy applications revealed many new insights of cellular processes in living plant cells as well as in whole plants.     

Mass spectrometry imaging for drug distribution studies

Since its introduction mass spectrometry imaging (MSI) has proven to be a powerful tool for the localization of molecules in biological tissues. In drug discovery and development, understanding the distribution of both drug and its metabolites is of critical importance. Traditional methods suffer from a lack of spatial information (tissue extraction followed by LCMS) or lack of specificity resulting in the inability to resolve parent drug from its metabolites (whole body autoradiography). MSI is a sensitive and label-free approach for imaging drugs and metabolites in tissues. In this article we review the different MSI technologies that have been applied to the imaging of pharmaceuticals. Recent technical advances, applications and current analytical limitations are discussed.     

Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin‐fixed paraffin‐embedded adenocarcinoma tissue sections

The identification of proteins involved in tumour progression or which permit enhanced or novel therapeutic targeting is essential for cancer research. Direct MALDI analysis of tissue sections is rapidly demonstrating its potential for protein imaging and profiling in the investigation of a range of disease states including cancer. MALDI‐mass spectrometry imaging (MALDI‐MSI) has been used here for direct visualisation and in situ characterisation of proteins in breast tumour tissue section samples. Frozen MCF7 breast tumour xenograft and human formalin‐fixed paraffin‐embedded breast cancer tissue sections were used. An improved protocol for on‐tissue trypsin digestion is described incorporating the use of a detergent, which increases the yield of tryptic peptides for both fresh frozen and formalin‐fixed paraffin‐embedded tumour tissue sections. A novel approach combining MALDI‐MSI and ion mobility separation MALDI‐tandem mass spectrometry imaging for improving the detection of low‐abundance proteins that are difficult to detect by direct MALDI‐MSI analysis is described. In situ protein identification was carried out directly from the tissue section by MALDI‐MSI. Numerous protein signals were detected and some proteins including histone H3, H4 and Grp75 that were abundant in the tumour region were identified.     

Emerging technologies in mass spectrometry imaging

Mass spectrometry imaging (MSI) as an analytical tool for bio-molecular and bio-medical research targets accurate compound localization and identification. In terms of dedicated instrumentation, this translates into the demand for more detail in the image dimension (spatial resolution) and in the spectral dimension (mass resolution and accuracy), preferably combined in one instrument. At the same time, large area biological tissue samples require fast acquisition schemes, instrument automation and a robust data infrastructure. This review discusses the analytical capabilities of an "ideal" MSI instrument for bio-molecular and bio-medical molecular imaging. The analytical attributes of such an ideal system are contrasted with technological and methodological challenges in MSI. In particular, innovative instrumentation for high spatial resolution imaging in combination with high sample throughput is discussed. Detector technology that targets various shortcomings of conventional imaging detector systems is highlighted. The benefits of accurate mass analysis, high mass resolving power, additional separation strategies and multimodal three-dimensional data reconstruction algorithms are discussed to provide the reader with an insight in the current technological advances and the potential of MSI for bio-medical research.     

Molecular network strategy in multi-omics and mass spectrometry imaging

Human physiological activities and pathological changes arise from the coordinated interactions of multiple molecules. Mass spectrometry (MS)-based multi-omics and MS imaging (MSI)-based spatial omics are powerful methods used to investigate molecular information related to the phenotype of interest from homogenated or sliced samples, including the qualitative, relative quantitative and spatial distributions. Molecular network strategy provides efficient methods to help us understand and mine the biological patterns behind the phenotypic data. It illustrates and combines various relationships between molecules, and further performs the molecule identification and biological interpretation. Here, we describe the recent advances of network-based analysis and its applications for different biological processes, such as, obesity, central nervous system diseases, and environmental toxicology.